Bain Capital Life Sciences Fund, L.P.
Related Filers (16)
- Bain Capital Life Sciences Investors, LLC (18)
- Bain Capital Life Sciences Partners, LP (18)
- BCIP Life Sciences Associates, LP (18)
- Schwartz Jeffrey Lawrence (16)
- Koppel Adam (15)
- DYNAVAX TECHNOLOGIES CORP (12)
- Dicerna Pharmaceuticals Inc (11)
- Annexon, Inc. (8)
- MARINUS PHARMACEUTICALS INC (7)
- Arcutis Biotherapeutics, Inc. (6)
- Aptinyx Inc. (6)
- Replimune Group, Inc. (4)
- X4 Pharmaceuticals, Inc (4)
- RAPID MICRO BIOSYSTEMS, INC. (3)
- Pharvaris N.V. (3)
- CONSTELLATION PHARMACEUTICALS INC (2)
- Show More ...
Other (31)
13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Tuesday, 10/24/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 10/10/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Tuesday, 8/8/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/14/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 5/18/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/16/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/15/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 2/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 8/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 5/15/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 2/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 11/14/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/14/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/15/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 2/14/2018
Initial Quarterly Form 13F Notice Report filed by institutional managers
D
Tuesday, 11/22/2016
Exempt (Private) Offering
Ownership (61)
SC 13G/A
Tuesday, 2/13/2024
Annexon, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13G/A
Monday, 1/22/2024
Pharvaris N.V.: Major Shareholders
SC 13G/A
Friday, 6/23/2023
Pharvaris N.V.: Major Shareholders
3
Tuesday, 5/30/2023
Annexon, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/30/2023
Annexon, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 5/30/2023
Annexon, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Annexon, Inc.: Major Shareholders
SC 13D/A
Wednesday, 8/17/2022
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13D/A
Monday, 8/8/2022
Arcutis Biotherapeutics, Inc.: Major Shareholders
SC 13D/A
Friday, 5/27/2022
Arcutis Biotherapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13G
Monday, 2/14/2022
RAPID MICRO BIOSYSTEMS, INC.: Major Shareholders
SC 13D/A
Friday, 8/27/2021
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13D/A
Wednesday, 8/11/2021
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
4
Wednesday, 7/21/2021
RAPID MICRO BIOSYSTEMS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/14/2021
RAPID MICRO BIOSYSTEMS, INC.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 6/11/2021
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13D/A
Friday, 3/26/2021
Aptinyx Inc.: Major Shareholders
SC 13G
Friday, 2/19/2021
Pharvaris N.V.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Replimune Group, Inc.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Annexon, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
CONSTELLATION PHARMACEUTICALS INC: Major Shareholders
SC 13D/A
Monday, 2/8/2021
Arcutis Biotherapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 12/14/2020
Dicerna Pharmaceuticals Inc: Major Shareholders
4
Tuesday, 10/27/2020
Aptinyx Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 10/27/2020
Aptinyx Inc.: Major Shareholders
4
Tuesday, 7/28/2020
Annexon, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Annexon, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 5/28/2020
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13D/A
Thursday, 3/12/2020
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13G/A
Friday, 2/14/2020
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13D
Friday, 2/7/2020
Arcutis Biotherapeutics, Inc.: Major Shareholders
4
Thursday, 2/6/2020
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/30/2020
Arcutis Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 1/16/2020
Aptinyx Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 1/16/2020
Aptinyx Inc.: Major Shareholders
SC 13G
Monday, 12/9/2019
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13D/A
Friday, 12/6/2019
Dicerna Pharmaceuticals Inc: Major Shareholders
SC 13D/A
Thursday, 11/21/2019
Dicerna Pharmaceuticals Inc: Major Shareholders
4
Thursday, 11/21/2019
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 10/11/2019
CONSTELLATION PHARMACEUTICALS INC: Major Shareholders
SC 13D
Thursday, 8/22/2019
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
4
Friday, 5/31/2019
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 5/31/2019
Dicerna Pharmaceuticals Inc: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
MARINUS PHARMACEUTICALS INC: Major Shareholders
SC 13G
Wednesday, 8/1/2018
Replimune Group, Inc.: Major Shareholders
4
Thursday, 7/26/2018
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/19/2018
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 7/3/2018
Aptinyx Inc.: Major Shareholders
4
Tuesday, 12/19/2017
MARINUS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 12/19/2017
MARINUS PHARMACEUTICALS INC: Major Shareholders
4
Tuesday, 12/19/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 12/19/2017
Dicerna Pharmaceuticals Inc: Major Shareholders
SC 13G
Thursday, 9/28/2017
MARINUS PHARMACEUTICALS INC: Major Shareholders
3
Thursday, 9/28/2017
MARINUS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 9/18/2017
Dicerna Pharmaceuticals Inc: Major Shareholders
SC 13D
Thursday, 4/13/2017
Dicerna Pharmaceuticals Inc: Major Shareholders
3
Thursday, 4/13/2017
Dicerna Pharmaceuticals Inc: Initial statement of beneficial ownership of securities